New York, March 2, 2026, 15:46 (EST) — Regular session
UnitedHealth Group Incorporated (UNH) shares were little changed on Monday as investors tracked a fresh burst of Medicare regulation risk in managed care. UnitedHealth stock was up about 0.2% at $293.71 in afternoon trade.
The backdrop matters because Medicare Advantage — the privately run version of U.S. Medicare — has become a key earnings engine for big insurers. And “risk adjustment,” the system that pays insurers more for sicker members based on diagnosis codes, is where small compliance shifts can swing dollars.
In its annual report filed on Monday, UnitedHealth said Medicare Advantage and Medicare Part D premiums can be adjusted retroactively under the Centers for Medicare & Medicaid Services’ risk-adjustment methodology and are subject to government review and audits. It said some local plans have been selected for risk adjustment data validation (RADV) audits — checks that diagnoses submitted for payment are backed by medical records — which can trigger payment clawbacks, fines or other actions. The filing showed UnitedHealthcare served about 8.4 million Medicare Advantage members as of Dec. 31, 2025. 1
The renewed focus followed a disclosure from Elevance Health that CMS intends to impose sanctions that would suspend enrollment in its Medicare Advantage prescription drug plans. Barclays analyst Andrew Mok called the move “a negative regulatory signal,” even if an enrollment pause is unlikely to be a near-term earnings hit. Elevance said it was reviewing the letter and would engage with CMS, and said any suspension would not affect current members. 2
Elevance shares were down about 9%, while Humana fell about 2.5% and Cigna slipped fractionally. UnitedHealth was one of the few large managed-care names holding around flat on the day.
UnitedHealth also filed for an accounting leadership shuffle. The company named Dennis Stankiewicz chief accounting officer effective March 2 and said Thomas Roos will become Optum Insight’s chief financial officer. 3
Separately, longtime executive Heather Cianfrocco said she was leaving UnitedHealth after 24 years. “I am leaving with so much pride” in what the team accomplished, she wrote on LinkedIn, according to Healthcare Dive. 4
The stock’s muted move comes after a sharp reset in late January, when UnitedHealth warned of its first revenue decline in decades and the federal Medicare agency proposed a near-flat 2027 rate update for Medicare Advantage plans. That episode pulled the group lower and left investors jumpy around rate and audit headlines. 5
But the bigger risk for UnitedHealth is that tougher enforcement becomes routine. A Senate committee report in January accused the insurer of aggressive risk-adjustment coding to boost Medicare payments; UnitedHealth disputed the characterisation and said it complies with applicable requirements. 6
Traders now watch whether the Elevance case spreads beyond one company. In its filing, Elevance said it must submit a written rebuttal by March 10 and that the sanctions are set to start March 31 unless CMS is satisfied the issues are fixed. 7
